CASI EV/EBITDA
-1.31
0.000.00%
Fri, 17 Jan 2025 21:57:05 GMT
Summary:
As of January 21, 2025, CASI EV/EBITDA is -1.31, unchanged from the previous trading day. Over the past year, it has increased by +1.43 (+52.19%). CASI EV/EBITDA is now -245.56% below its all-time high of 0.90.CASI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | 0.0% |
1 m1 month | +7.8% |
3 m3 months | +52.7% |
6 m6 months | +64.8% |
ytdytd | +10.9% |
1 y1 year | +52.2% |
5 y5 years | +81.0% |
CASI EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -1.31 | at high | -1.69 | +22.5% |
3 m | 3-month | -1.31 | at high | -3.11 | +57.9% |
6 m | 6-month | -1.31 | at high | -4.20 | +68.8% |
1 y | 1-year | -1.31 | at high | -4.20 | +68.8% |
3 y | 3-year | 0.90 | -245.6% | -4.20 | +68.8% |
5 y | 5-year | 0.90 | -245.6% | -12.63 | +89.6% |
alltime | all time | 0.90 | -245.6% | -66.20 | +98.0% |
CASI Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -1.31(-10.9%) |
2024 | -1.47(-62.2%) |
2023 | -3.89(-532.2%) |
2022 | 0.90(-140.0%) |
2021 | -2.25(-77.4%) |
2020 | -9.94(+49.7%) |
2019 | -6.64(-43.8%) |
2018 | -11.81(-32.0%) |
2017 | -17.38(+273.0%) |
2016 | -4.66(+19.5%) |
2015 | -3.90(+200.0%) |
2014 | -1.30(-75.2%) |
2013 | -5.25(+2.3%) |
2012 | -5.13(+120.2%) |
2011 | -2.33(-80.9%) |
Date | Value |
---|---|
2010 | -12.18(+9.2%) |
2009 | -11.15(+1427.4%) |
2008 | -0.73(-81.1%) |
2007 | -3.87(-25.6%) |
2006 | -5.20(+2.4%) |
2005 | -5.08(-32.0%) |
2004 | -7.47(+58.6%) |
2003 | -4.71(>+9900.0%) |
2002 | -0.04(-98.2%) |
2001 | -2.23(-58.2%) |
2000 | -5.33(-42.3%) |
1999 | -9.24(-43.4%) |
1998 | -16.32(+16.6%) |
1997 | -14.00(-47.3%) |
1996 | -26.56 |
FAQ
- What is CASI Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for CASI Pharmaceuticals?
- What is CASI EV/EBITDA year-to-date change?
- What is CASI Pharmaceuticals EV/EBITDA year-on-year change?
What is CASI Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CASI is -1.31
What is the all time high EV/EBITDA for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high EV/EBITDA is 0.90
What is CASI EV/EBITDA year-to-date change?
CASI Pharmaceuticals EV/EBITDA has changed by +0.16 (+10.88%) since the beginning of the year
What is CASI Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CASI EV/EBITDA has changed by +1.43 (+52.19%)